Form 4 for GILD Gilead Sciences
Accepted 2025-07-28 00:00:00 ET · period of report 2025-07-25 · accession 0001127602-25-019654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-28 | 2025-07-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | +8,743 | 46.5K | +23% | — |
| D | 2025-07-28 | 2025-07-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | F - Tax | $116.20 | -3,823 | 42.7K | -8% | -$444.2K |
| DM | 2025-07-28 | 2025-07-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | -8,743 | 21.6K | -29% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-25 | M | A | 514 | — | 38,315 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2025-07-25 | M | A | 8,229 | — | 46,544 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Common | Common Stock | 2025-07-25 | F | D | 3,823 | $116.20 | 42,721 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2025-07-25 | M | D | 514 | — | 29,875 | D | — · — to — | 514 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2025-07-25 | M | D | 8,229 | — | 21,646 | D | — · — to — | 8,229 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a three-year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested. |